A breakthrough is only half the story.
Arc Biogenics is a global discovery company. We work on the other half, the distance between a breakthrough and a life it actually reaches.
Who we are
We start where medicine usually stops.
Most of medicine's progress happens inside the molecule. Very little of it happens in the moment someone actually has to take it, the pill that is hard to swallow, the routine that is hard to keep. That quiet gap is where good discoveries fail. It is also where Arc chose to work.
We develop our own delivery science and advance fourteen programs across six areas of focus, from immunology to rare diseases, held to one test above all others: can a real person live with it?
Working for people, everywhere
Why we exist
Around 1 in 25 adults cannot easily swallow medication. More than a third struggle with ordinary tablets and capsules. A child. Someone elderly. Anyone already unwell. The format of medicine should never be the reason it goes untaken.
People, not patients
Everything we make begins and ends with a human life, never a condition, never a statistic.
What we hold to
Three things we don't compromise.
The person, before the patient
We design for a life first and a condition second. If a medicine doesn't fit the way someone actually lives, we don't consider it finished.
Proof, not promise
We would rather demonstrate something quietly than claim it loudly. Evidence sets the pace, always.
Finish the last mile
The discovery is only the beginning. Our work is everything between the laboratory and the moment medicine reaches a hand.
How Arc is organised
One company, many disciplines.
The work is broad, but the thread is single: discovery, made to reach people. Three parts of the company carry it forward.
Build with us